Skip to main content

Equibles does not estimate personal net worth.

About Thomas Jensen

Thomas Jensen is recorded as CEO at Allarity Therapeutics, Inc. (ALLR) since December 8, 2023 and Board Member at Allarity Therapeutics, Inc. (ALLR) since July 7, 2022. Allarity Therapeutics, Inc. reported in an 8-K filed December 11, 2023 that Thomas Jensen was appointed Chief Executive Officer, effective December 8, 2023. Allarity Therapeutics, Inc. reported in an 8-K filed July 11, 2022 that Thomas Jensen was appointed Class I Director, effective July 7, 2022. Allarity Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Allarity Therapeutics, Inc. includes Steve R. Carchedi (CEO), Thomas H. Jensen (CEO and Board Member), Gerald W. McLaughlin (Chairman and Board Member) and 7 others.

“On December 8, 2023, Mr. Thomas Jensen, age 45, was appointed by the Company’s Board of Directors as Chief Executive Officer.”
Allarity Therapeutics, Inc. Form 8-K, filed December 11, 2023 · Read the filing
“Class I Director: Thomas Jensen, whose term will expire at the Company's first annual meeting of stockholders held after December 2021, or until his successor shall have been duly elected and qualified, or until his earlier death, resignation, or removal;”
Allarity Therapeutics, Inc. Form 8-K, filed July 11, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Allarity Therapeutics, Inc.

Recent activity